Cargando…
Mass Customized Outlook for Regenerative Heart Failure Care
Heart failure pathobiology is permissive to reparative intent. Regenerative therapies exemplify an emerging disruptive innovation aimed at achieving structural and functional organ restitution. However, mixed outcomes, complexity in use, and unsustainable cost have curtailed broader adoption, mandat...
Autores principales: | Yamada, Satsuki, Bartunek, Jozef, Behfar, Atta, Terzic, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583673/ https://www.ncbi.nlm.nih.gov/pubmed/34768825 http://dx.doi.org/10.3390/ijms222111394 |
Ejemplares similares
-
Screening for regenerative therapy responders in heart failure
por: Yamada, Satsuki, et al.
Publicado: (2021) -
Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
por: Yamada, Satsuki, et al.
Publicado: (2019) -
Regenerative heart failure therapy headed for optimization
por: Terzic, Andre, et al.
Publicado: (2014) -
Clinical development plan for regenerative therapy in heart failure
por: Terzic, Andre, et al.
Publicado: (2016) -
Endpoints in stem cell trials in ischemic heart failure
por: Banovic, Marko, et al.
Publicado: (2015)